Skip to main content

Table 3 Changes of characteristics of severe HFMD caused by EV71 in the non-CVVHDF group and the CVVHDF group

From: Continuous hemodiafiltration as a rescue therapy for patients with cardiopulmonary failure caused by enterovirus-71: a retrospective observational study in a PICU

Variables

Non-CVVHDF group

(nā€‰=ā€‰12)

CVVHDF group

(nā€‰=ā€‰17)

Pā€

1st day (A1)

3rd day (A2)

P

Before CVVHDF (B1)

72ā€‰h after CVVHDF (B2)

Pā€™

Vital signs

ā€ƒHeart rate, bpm

188.0 (170.8, 194.8)

142.0 (130.3, 157.0)

0.001

187.0 (178.0, 197.5)

134.0 (122.5, 147.0)

0.001

0.143

ā€ƒBody temperature, oC

39.7 (39.4, 39.8)

38.0 (37.3, 38.5)

0.001

39.7 (39.3, 40.0)

36.8 (36.4, 37.3)

0.001

0.001

ā€ƒSystolic blood pressure, mmHg

132.0 (76.0, 150.5)

121.5 (103.5, 140.3)

0.854

139 (101.5, 155.0)

102.5 (86.5, 115.7)

0.003

0.001

Cardiac parameters

ā€ƒLVEF, %

38 (26, 44)

41 (29, 46)

0.204

37 (21, 47)

55 (21, 62)

0.017

0.184

ā€ƒCI, L/min/m2

2.89 (2.23, 3.63)

3.11 (2.22, 3.73)

0.621

2.73 (1.92, 3.95)

4.77 (1.92, 5.75)

0.002

0.199

ā€ƒcTnI, Ī¼g/L

0.16 (0.06, 0.38)

0.08 (0.04, 0.15)

0.032

0.12 (0.06, 0.39)

0.02 (0.01, 0.48)

0.365

0.325

ā€ƒCK-MB, IU/L

35.0 (20.5, 72.8)

33.0 (19.0, 64.3)

0.240

37.0 (25.5, 112.0)

78.0 (39.0, 110.5)

0.298

0.008

Organ function indexes

ā€ƒBlood glucose, mg/dL

9.85 (6.98, 12.18)

7.9 (6.95, 10.35)

0.311

9.4 (7.9, 11.3)

6.1 (5.7, 11.8)

0.118

0.057

ā€ƒLac, mmol/L

4.35 (3.20, 5.80)

2.2 (1.93, 3.75)

0.014

3.50 (2.75, 3.90)

1.3 (0.95, 1.90)

0.001

0.005

ā€ƒpH

7.21 (6.94, 7.37)

7.31 (7.21, 7.38)

0.015

7.23 (7.07, 7.31)

7.39 (7.37, 7.44)

0.001

0.041

ā€ƒCr, Ī¼mol/L

58.0 (28.5, 79.8)

61.0 (54.5, 119.5)

0.121

48.0 (28.0, 77.0)

38.0 (20.5, 72.0)

0.517

0.023

ā€ƒALT, IU/L

36.0 (19.8, 63.3)

63.0 (27.0, 140.8)

0.048

35.0 (12.5, 70.0)

38.0 (26.0, 52.0)

0.227

0.170

Catecholamine

ā€ƒAdrenalin, ng/L

153.6 (127.0, 184.4)

145.4 (85.8, 175.1)

0.190

169.8 (145.5, 244.6)

148.0 (109.0, 208.1)

0.033

0.223

ā€ƒDopamine, ng/L

127 (82.4, 156.5)

133.4 (83.0, 171.7)

0.678

152.7 (97.0, 191.1)

96.0 (68.0, 160.9)

0.026

0.319

RAAS substances

ā€ƒRenin, Ī¼g/L.h

2.35 (1.49, 4.76)

2.90 (1.30, 4.80)

0.872

1.12 (0.74, 3.45)

0.79 (0.52, 1.25)

0.029

0.003

ā€ƒAngiotensinII, ng/L

348.4 (131.5, 773.0)

565.4 (210.9, 773.3)

0.215

185.9 (125.2, 800.0)

106.0 (90.8, 232.5)

0.047

0.001

ā€ƒAldosterone, ng/L

211.2 (119.8, 362.6)

281.9 (167.9, 349.0)

0.730

165.7 (94.0, 353.3)

103.3 (84.3, 144.3)

0.033

0.001

  1. LVEF Left ventricular ejection fraction, CI Cardiac index, cTnI Cardiac troponin I, CK-MB Creatine kinase-MB, Lac Lactate, Cr Creatinine, ALT Alanine transaminase. Continuous variables were summarized as the median (IQR). P indicates A1 vs. A2; Pā€² indicates B1 vs. B2; Pā€³ indicates A2 vs. B2